Skip to content
★ Sign in to follow
RE

Robert E. Engle

Executive
Yield10 Bioscience, Inc.
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€57k
▼ Sales (0 ops.)
—

Latest filing published 04 Dec 2012 for YIELD10 BIOSCIENCE, INC., €21k.

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
2

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Robert E. Engle: trading record in brief

This profile gathers the share dealings of Robert E. Engle in Yield10 Bioscience, Inc. The record holds 2 filings, for trades running from 24 May 2011 to 30 November 2012.

No open-market sale appears; the market trades are 2 purchases worth €57k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. So far in 2012, the count stands at 1 purchase and no sales.

Most recently, on 4 December 2012, the filings show an open-market purchase worth €21k in Yield10 Bioscience, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Robert E. Engle

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    VP BiopolymersExecutivesYield10 Bioscience, Inc.
    26,750 USD0SEC
    25,000 shares@ US$1.07Common StockSEC:0001179110-12-016845:0
    Canonical exit: 28 Feb 2013 (T+90)
  • ▲
    General Manager, TellesExecutivesYield10 Bioscience, Inc.
    50,750 USD0SEC
    7,000 shares@ US$7.25Common StockSEC:0001179110-11-008656:0
    Canonical exit: 22 Aug 2011 (T+90)

2 of 2 declarations